Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus versus tacrolimus as delayed treatment after non-heart-beating donor kidney transplantation
2006-001265-41Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Apr 2006
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in end-stage kidney disease (ESKD) and Kidney allograft status (RTx) comparing Sirolimus arm with Tacrolimus arm (2 arms). Primary endpoints: Renal function (creatinine) and Renal function (calculated GFR). Started Apr 2006; status: completed.
02
Drugs
sirolimustacrolimus
03
Conditions
end-stage kidney disease (ESKD)Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2006-001265-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001265-41.